Relationship Between Native Papillary Muscle T Time and Severity of Functional Mitral Regurgitation in Patients with Non-ischemic Dilated Cardiomyopathy
Overview
Radiology
Authors
Affiliations
Background: Functional mitral regurgitation is one of the severe complications of non-ischemic dilated cardiomyopathy (DCM). Non-contrast native T mapping has emerged as a non-invasive method to evaluate myocardial fibrosis. We sought to evaluate the potential relationship between papillary muscle T time and mitral regurgitation in DCM patients.
Methods: Forty DCM patients (55 ± 13 years) and 20 healthy adult control subjects (54 ± 13 years) were studied. Native T mapping was performed using a slice interleaved T mapping sequence (STONE) which enables acquisition of 5 slices in the short-axis plane within a 90 s free-breathing scan. We measured papillary muscle diameter, length and shortening. DCM patients were allocated into 2 groups based on the presence or absence of functional mitral regurgitation.
Results: Papillary muscle T time was significantly elevated in DCM patients with mitral regurgitation (n = 22) in comparison to those without mitral regurgitation (n = 18) (anterior papillary muscle: 1127 ± 36 msec vs 1063 ± 16 msec, p < 0.05; posterior papillary muscle: 1124 ± 30 msec vs 1062 ± 19 msec, p < 0.05), but LV T time was similar (1129 ± 38 msec vs 1134 ± 58 msec, p = 0.93). Multivariate linear regression analysis showed that papillary muscle native T time (β = 0.10, 95 % CI: 0.05-0.17, p < 0.05) is significantly correlated with mitral regurgitant fraction. Elevated papillary muscle T time was associated with larger diameter, longer length and decreased papillary muscle shortening (all p values <0.05).
Conclusions: In DCM, papillary muscle native T time is significantly elevated and related to mitral regurgitant fraction.
Beijnink C, Raafs A, Vos J, Verdonschot J, Sikking M, Rodwell L JACC Adv. 2024; 3(8):101103.
PMID: 39105114 PMC: 11298879. DOI: 10.1016/j.jacadv.2024.101103.
Left Ventricular Papillary Muscle: Anatomy, Pathophysiology, and Multimodal Evaluation.
Li S, Wang Z, Fu W, Li F, Gu H, Cui N Diagnostics (Basel). 2024; 14(12).
PMID: 38928685 PMC: 11202998. DOI: 10.3390/diagnostics14121270.
Fang Q, Huang K, Yao X, Peng Y, Kan A, Song Y Quant Imaging Med Surg. 2023; 13(10):7012-7028.
PMID: 37869323 PMC: 10585513. DOI: 10.21037/qims-23-34.
Federspiel J, Gartner J, Lipp P, Schmidt P, Tschernig T J Cardiovasc Dev Dis. 2023; 10(1).
PMID: 36661921 PMC: 9861266. DOI: 10.3390/jcdd10010026.
Focus on Diagnosis and Prognosis to Guide Timing of Intervention in Valvular Heart Disease.
Stassen J, Galloo X, Van der Bijl P, Bax J Curr Cardiol Rep. 2022; 24(10):1407-1416.
PMID: 35925514 PMC: 9556368. DOI: 10.1007/s11886-022-01754-w.